Clearmind Medicine Inc. Equity
Clearmind Medicine Inc. (CMND) had Equity of $8.24 million as of 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-03-12
- 2023-01-31: Equity 5.14M CAD.
- 2022-10-31: Equity -1.51M CAD.
- 2022-01-31: Equity 3.07M CAD.
- 2021-10-31: Equity 4.80M CAD.
CAD
| Period end | Equity |
|---|---|
| 2023-01-31 | 5.14M CAD 6-K · filed 2023-03-17 |
| 2022-10-31 | -1.51M CAD 6-K · filed 2023-03-17 |
| 2022-01-31 | 3.07M CAD 6-K · filed 2023-03-17 |
| 2021-10-31 | 4.80M CAD 6-K · filed 2023-03-17 |
| 2020-10-31 | 319.60K CAD 20-F · filed 2023-02-06 |
| 2019-10-31 | 133.81K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Equity | Equity as first filed |
|---|---|---|
| 2026-01-31 | $8.24M 6-K · filed 2026-03-12 | |
| 2025-10-31 | $1.19M 6-K · filed 2026-03-12 | |
| 2025-07-31 | $1.07M 6-K · filed 2025-09-11 | |
| 2025-04-30 | $2.30M 6-K · filed 2025-06-12 | |
| 2025-01-31 | $2.85M 6-K · filed 2026-03-12 | |
| 2024-10-31 | $3.11M 6-K · filed 2026-03-12 | |
| 2024-07-31 | $3.47M 6-K · filed 2025-09-11 | |
| 2024-04-30 | $4.65M 6-K · filed 2025-06-12 | |
| 2024-01-31 | $5.04M 6-K · filed 2025-03-13 | |
| 2023-10-31 | $983.47K 20-F · filed 2026-01-20 | |
| 2023-07-31 | $2.78M 6-K · filed 2024-09-16 | |
| 2023-04-30 | $3.27M 6-K · filed 2024-06-13 | $3.34M 6-K · filed 2023-06-14 |
| 2023-01-31 | $3.84M 6-K · filed 2024-03-19 | |
| 2022-10-31 | -$1.11M 20-F · filed 2026-01-20 | |
| 2022-04-30 | $1.33M 6-K · filed 2023-06-14 | |
| 2021-10-31 | $3.52M 20-F · filed 2025-01-22 | $3.51M 6-K · filed 2023-06-14 |
| 2020-10-31 | $234.16K 20-F/A · filed 2024-03-18 |